A Pilot Study of 18F-FDG PET-CT Kinetic Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who is this study for? Adult patients with Non-Nasopharynx Head and Neck Mucosal Squamous Cell Carcinoma
What treatments are being studied? Fluorodeoxyglucose (18F FDG)
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to see how useful the information provided from Positron Emission Tomography (PET) scans can be in the actual planning and delivery of radiation treatment to patients who have head and neck cancers. Patients participating in this study, will have (in addition to their routine tests) a PET scan before and during their radiation treatment. Following the intervention, patients will be followed as per standard practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Non-nasopharynx head and neck mucosal squamous cell carcinoma

• Radiologically evident gross disease

• Radiotherapy alone for curative intent

• Age equal to or more than 18 years old

• To be eligible for the second study PET-CT scan: FDG avid tumour (or minimum SUV of 2.5) on the first study PET-CT scan

Locations
Other Locations
Canada
University Health Network, Princess Margaret Cancer Center
RECRUITING
Toronto
Contact Information
Primary
John J Kim, MD
John.kim@rmp.uhn.on.ca
416 946 4501
Backup
Stephen Breen, PhD
Stephen.Breen@rmp.uhn.on.ca
416 946 4501
Time Frame
Start Date: 2014-10
Estimated Completion Date: 2028-11
Participants
Target number of participants: 20
Treatments
Experimental: HNSCC Patients receiving RT
Related Therapeutic Areas
Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsors
Leads: University Health Network, Toronto

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

A Single Arm Phase II Trial Evaluating Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

A Single Arm Phase II Trial Evaluating Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Enrollment Status: Recruiting
Publish Date: November 07, 2025
Intervention Type: Diagnostic test, Radiation, Other
Study Phase: Phase 2

Effects of Rice Bran on Radiation-Induced Oral Mucositis in Patients With Head/Neck Cancer and Its Impact on the Quality of Life

Effects of Rice Bran on Radiation-Induced Oral Mucositis in Patients With Head/Neck Cancer and Its Impact on the Quality of Life

Enrollment Status: Recruiting
Publish Date: November 21, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Drug
Study Phase: Phase 2
View All